LMG Life Sciences 2012 – Highly Recommended for Licensing and Collaboration, and for White Collar and Government Investigations. Recommended for FDA – Pharmaceuticals; Healthcare: Pricing and Reimbursement; Patent Prosecution; General Patent Litigation; Corporate; and Competition and Antitrust
PLCCross-border Quarterly 2012 Life Sciences Legal Market Review
- Life Sciences Regulatory Super League - Ranked 8th among law firms worldwide
PLCCross-border Life Sciences Handbook 2011/12
- U.S.:
- Commercial and Partnering - Highly Recommended
- Competition/Antitrust - Highly Recommended
- Corporate - Recommended
- Government Enforcement and Investigations - Highly Recommended
- Regulatory - Recommended
- Regulatory (Medical Devices) - Recommended
- England: Regulatory - Recommended
- Japan: Corporate and Commercial - Recommended
Chambers Global 2012: Global Life Sciences - Recommended - Band 3
Chambers USA 2012: National for Life Sciences - Band 3; Washington, D.C. for healthcare/ pharmaceutical/ medical products regulatory - Band 3
UK Legal 500 2010: London: Pharmaceuticals and Biotechnology
Best Lawyers in America 2011: Biotechnology and Healthcare Law Named
BioPharm Insight 2012
- Ranked 3rd - Global League Table of Legal Advisers to Biotech and Pharma Licensing Agreements - Based upon Value
- Ranked 4th - Global League Table of Legal Advisers to Biotech and Pharma Licensing Agreements - Based upon Volume
- Ranked 10th - Legal Advisors to Biotech and Pharma Licensing Agreements: North America - Based upon Value
- Ranked 5th - Legal Advisors to Biotech and Pharma Licensing Agreements: North America - Based upon Volume
- Ranked 2nd - Legal Advisors to Biotech and Pharma Licensing Agreements: Europe - Based upon Value
- Ranked 3rd - Legal Advisors to Biotech and Pharma Licensing Agreements: Europe - Based upon Volume
- Ranked 2nd - Legal Advisors to Biotech and Pharma Licensing Agreements: Asia-Pacific - Based upon Value
- Ranked 3rd - Legal Advisors to Biotech and Pharma Licensing Agreements: Asia-Pacific - Based upon Volume
U.S. News & World Report/Best Lawyers 2010: Ranked Tier 1 National Practice - Biotechnology
